Interleukin-10 limits intense acute swimming-induced muscle mechanical hyperalgesia in mice

Experimental Physiology

Volumn 100, Issue 5, 2015, Pages 531-544

  Borghi, Sergio M ^a   Pinho Ribeiro, Felipe A ^a   Zarpelon, Ana C ^a   Cunha, Thiago M ^b   Alves Filho, Jose C ^b   Ferreira, Sergio H ^b   Cunha, Fernando Q ^b   Casagrande, Rubia ^a   Verri, Waldiceu A ^a  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; GLUCOSE; GLUTATHIONE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 5; MYELOPEROXIDASE; RECOMBINANT INTERLEUKIN 10; SUPEROXIDE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; IL10 PROTEIN, MOUSE;

ANALGESIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CYTOKINE PRODUCTION; ENZYME ACTIVITY; EXERCISE INTENSITY; FEMALE; GASTROCNEMIUS MUSCLE; GLUCOSE BLOOD LEVEL; JOINT FUNCTION; LEUKOCYTE MIGRATION; MECHANICAL HYPERALGESIA; MOUSE; MYALGIA; NONHUMAN; OXIDATIVE STRESS; PAIN RECEPTOR; PROTEIN BLOOD LEVEL; PROTEIN DEPLETION; PROTEIN FUNCTION; SKELETAL MUSCLE; SOLEUS MUSCLE; SWIMMING; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; CYTOLOGY; GENETICS; HYPERALGESIA; INFLAMMATION; MALE; METABOLISM; MUSCLE CELL; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; HYPERALGESIA; INFLAMMATION; INTERLEUKIN-10; MALE; MICE, INBRED C57BL; MUSCLE CELLS; MUSCLE, SKELETAL; MYALGIA; OXIDATIVE STRESS; SWIMMING;

EID: 84929028500     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/EP085026     Document Type: Article

References (56)

1. Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, Klunker S, Meyer N, O'Mahony L, Palomares O, Rhyner C, Ouaked N, Schaffartzik A, VanDe Veen W, Zeller S, Zimmermann M & Akdis CA (2011). Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J Allergy Clin Immunol 127, 701-721.e70.
2. Binshtok AM, Wang H, Zimmermann K, Amaya F, Vardeh D, Shi L, Brenner GJ, Ji RR, Bean BP, Woolf CJ & Samad TA (2008). Nociceptors are interleukin-1β sensors. J Neurosci 28, 14062-14073.
3. Borghi SM, Carvalho TT, Staurengo-Ferrari L, Hohmann MS, Pinge-Filho P, Casagrande R & Verri WA Jr (2013). Vitexin inhibits inflammatory pain in mice by targeting TRPV1, oxidative stress, and cytokines. J Nat Prod 76, 1141-1149.
4. Borghi SM, Zarpelon AC, Pinho-Ribeiro FA, Cardoso RD, Martins-Pinge MC, Tatakihara RI, Cunha TM, Ferreira SH, Cunha FQ, Casagrande R & Verri WA Jr (2014b). Role of TNF-α/TNFR1 in intense acute swimming-induced delayed onset muscle soreness in mice. Physiol Behav 128, 277-287.
5. Borghi SM, Zarpelon AC, Pinho-Ribeiro FA, Cardoso RD, Cunha TM, Alves-Filho JC, Ferreira SH, Cunha FQ, Casagrande R & VerriJr Jr WA (2014a). Targeting interleukin-1β reduces intense acute swimming-induced muscle mechanical hyperalgesia in mice. J Pharm Pharmacol 66, 1009-1020.
6. Chatzinikolaou A, Fatouros IG, Gourgoulis V, Avloniti A, Jamurtas AZ, Nikolaidis MG, Douroudos I, Michailidis Y, Beneka A, Malliou P, Tofas T, Georgiadis I, Mandalidis D & Taxildaris K (2010). Time course of changes in performance and inflammatory responses after acute plyometric exercise. J Strength Cond Res 24, 1389-1398.
7. Cleto LS, Oleto AF, Sousa LP, Barreto TO, Cruz JS, Penaforte CL, Magalhães JC, Sousa-Franco J, Pinto KM, Campi-Azevedo AC & Rocha-Vieira E (2011). Plasma cytokine response, lipid peroxidation and NF-kB activation in skeletal muscle following maximum progressive swimming. Braz J Med Biol Res 44, 546-552.
8. Cunha FQ, Poole S, Lorenzetti BB, Veiga FH & Ferreira SH (1999). Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4. Br J Pharmacol 126, 45-50.
9. Cunha TM, Verri WA Jr, Vivancos GG, Moreira IF, Reis S, Parada CA, Cunha FQ & Ferreira SH (2004). An electronic pressure-meter nociception paw test for mice. Braz J Med Biol Res 37, 401-407.
10. da Silva MD, Bobinski F, Sato KL, Kolker SJ, Sluka KA & Santos AR (2014). IL-10 cytokine released from M2 macrophages is crucial for analgesic and anti-inflammatory effects of acupuncture in a model of inflammatory muscle pain. Mol Neurobiol 51, 19-31.
11. Davis JM, Murphy EA, Carmichael MD, Zielinski MR, Groschwitz CM, Brown AS, Gangemi JD, Ghaffar A & Mayer EP (2007). Curcumin effects on inflammation and performance recovery following eccentric exercise-induced muscle damage. Am J Physiol Regul Integr Comp Physiol 292, R2168-R2173.
12. Donnelly RP, Dickensheets H & Finbloom DS. The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes (1999). J Interferon Cytokine Res 19, 563-573.
13. Ellis A & Bennett DL (2013). Neuroinflammation and the generation of neuropathic pain. Br J Anaesth 111, 26-37.
14. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M & O'Garra A (1990). IL-10 inhibits cytokine production by activated macrophages. J Immunol 147, 3815-3822.
15. Graven-Nielsen T & Arendt-Nielsen L (2003). Induction and assessment of muscle pain, referred pain, and muscular hyperalgesia. Curr Pain Headache Rep 7, 443-451.
16. Hovsepian E, Penas F, Siffo S, Mirkin GA & Goren NB (2013). IL-10 inhibits the NF-κB and ERK/MAPK-mediated production of pro-inflammatory mediators by up-regulation of SOCS-3 in Trypanosoma cruzi-infected cardiomyocytes. PLoS One 8, e79445.
17. Hu S, Mao-Ying QL, Wang J, Wang ZF, Mi WL, Wang XW, Jiang JW, Huang YL, Wu GC & Wang YQ (2012). Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines. J Neuroinflammation 9, 278.
18. Inoue M, Arikawa T, Chen YH, Moriwaki Y, Price M, Brown M, Perfect JR & Shinohara ML (2014). T cells down-regulate macrophage TNF production by IRAK1-mediated IL-10 expression and control innate hyperinflammation. Proc Natl Acad Sci U S A 111, 5295-5300.
19. Jamurtas AZ, Garyfallopoulou A, Theodorou AA, Zalavras A, Paschalis V, Deli CK, Nikolaidis MG, Fatouros IG & Koutedakis Y (2013). A single bout of downhill running transiently increases HOMA-IR without altering adipokine response in healthy adult women. Eur J Appl Physiol 113, 2925-2932.
20. Jin X & Gereau RW 4th (2006). Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-α. J Neurosci 26, 246-255.
21. Kamizato M, Nishida K, Masuda K, Takeo K, Yamamoto Y, Kawai T, Teshima-Kondo S, Tanahashi T & Rokutan K (2009). Interleukin 10 inhibits interferon γ- and tumor necrosis factor α-stimulated activation of NADPH oxidase 1 in human colonic epithelial cells and the mouse colon. J Gastroenterol 44, 1172-1184.
22. Kanaan SA, Poole S, Saadé NE, Jabbur S & Safieh-Garabedian B (1998). Interleukin-10 reduces the endotoxin-induced hyperalgesia in mice. J Neuroimmunol 15, 142-150.
23. + natural regulatory T cells improves microvascular endothelial function through inhibition of NADPH oxidase activity in hypertensive mice. Arterioscler Thromb Vasc Biol 31, 2534-2542.
24. Kubo A, Koyama M, Tamura R, Takagishi Y, Murase S & Mizumura K (2012). Absence of mechanical hyperalgesia after exercise (delayed onset muscle soreness) in neonatally capsaicin-treated rats. Neurosci Res 73, 56-60.
25. Kuga S, Otsuka T, Niiro H, Nunoi H, Nemoto Y, Nakano T, Ogo T, Umei T & Niho Y (1996). Suppression of superoxide anion production by interleukin-10 is accompanied by a downregulation of the genes for subunit proteins of NADPH oxidase. Exp Hematol 24, 151-157.
26. Lewis PB, Ruby D & Bush-Joseph CA (2012). Muscle soreness and delayed-onset muscle soreness. Clin Sports Med 31, 255-262.
27. Loram LC, Fuller A, Fick LG, Cartmell T, Poole S & Mitchell D (2007). Cytokine profiles during carrageenan-induced inflammatory hyperalgesia in rat muscle and hind paw. J Pain 8, 127-136.
28. MacIntyre DL, Reid WD & McKenzie DC (1995). Delayed muscle soreness. The inflammatory response to muscle injury and its clinical implications. Sports Med 20, 24-40.
29. Magee P, Pearson S & Allen J (2008). The omega-3 fatty acid, eicosapentaenoic acid (EPA), prevents the damaging effects of tumor necrosis factor (TNF)-alpha during murine skeletal muscle cell differentiation. Lipids Health Dis 7, 24.
30. Milligan ED, Sloane EM, Langer SJ, Cruz PE, Chacur M, Spataro L, Wieseler-Frank J, Hammack SE, Maier SF, Flotte TR, Forsayeth JR, Leinwand LA, Chavez R & Watkins LR (2005). Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Mol Pain 1, 9.
31. Murase S, Kato K, Taguchi T & Mizumura K (2014). Glial cell line-derived neurotrophic factor sensitized the mechanixal response of muscular thin-fibre afferents in rats. Eur J Pain 18, 629-638.
32. Navarro SA, Serafim KG, Mizokami SS, Hohmann MS, Casagrande R & Verri WA Jr (2013). Analgesic activity of piracetam: effect on cytokine production and oxidative stress. Pharmacol Biochem Behav 105, 183- 192.
33. Nieman DC, Dumke CL, Henson DA, McAnulty SR, Gross SJ & Lind RH (2005). Muscle damage is linked to cytokine changes following a 160-km race. Brain Behav Immun 19, 398-403.
34. Nieman DC, Henson DA, Dumke CL, Oley K, McAnulty SR, Davis JM, Murphy EA, Utter AC, Lind RH, McAnulty LS & Morrow JD (2006). Ibuprofen use, endotoxemia, inflammation, and plasma cytokines during ultramarathon competition. Brain Behav Immun 20, 578-584.
35. Poole S, Cunha FQ, Selkirk S, Lorenzetti BB & Ferreira SH (1995). Cytokine-mediated inflammatory hyperalgesia limited by interleukin-10. Br J Pharmacol 115, 684-688.
36. Powers SK & Jackson MJ (2008). Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev 88, 1243-1276.
37. Qian L, Block ML, Wei SJ, Lin CF, Reece J, Pang H, Wilson B, Hong JS & Flood PM (2006). Interleukin-10 protects lipopolysaccharide-induced neurotoxicity in primary midbrain cultures by inhibiting the function of NADPH oxidase. J Pharmacol Exp Ther 319, 44-52.
38. Queme F, Taguchi T, Mizumura K & Graven-Nielsen T (2013). Muscular heat and mechanical pain sensitivity after lengthening contractions in humans and animals. J Pain 14, 1425-1436.
39. Sacerdote P, Franchi S, Moretti S, Castelli M, Procacci P, Magnaghi V & Panerai AE (2013). Cytokine modulation is necessary for efficacious treatment of experimental neuropathic pain. J Neuroimmune Pharmacol 8, 202-211.
40. Salvemini D, Little JW, Doyle T & Neumann WL (2011). Roles of reactive oxygen and nitrogen species in pain. Free Radic Biol Med 51, 951-966.
41. Schäfers M, Sorkin LS & Sommer C (2003). Intramuscular injection of tumor necrosis factor-alpha induces muscle hyperalgesia in rats. Pain 104, 579-588.
42. Shah JP, Danoff JV, Desai MJ, Parikh S, Nakamura LY, Phillips TM & Gerber LH (2008). Biochemicals associated with pain and inflammation are elevated in sites near to and remote from active myofascial trigger points. Arch Phys Med Rehabil 89, 16-23.
43. Shen KF, Zhu HQ, Wei XH, Wang J, Li YY, Pang RP & Liu XG (2013). Interleukin-10 down-regulates voltage gated sodium channels in rat dorsal root ganglion neurons. Exp Neurol 247, 466-475.
44. Shimizu K, Guo W, Wang H, Zou S, LaGraize SC, Iwata K, Wei F, Dubner R & Ren K (2009). Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: the effects of interleukin-10 and glial inhibitors. Mol Pain 5, 75.
45. Smith C, Kruger MJ, Smith RM & Myburgh KH (2008). The inflammatory response to skeletal muscle injury: illuminating complexities. Sports Med 38, 947-969.
46. Standiford TJ, Strieter RM, Chensue SW, Westwick J, Kasahara K & Kunkel SL (1990). IL-4 inhibits the expression of IL-8 from stimulated human monocytes. J Immunol 145, 1435-1439.
47. Taguchi T, Sato J & Mizumura K (2005). Augmented mechanical response of muscle thin-fiber sensory receptors recorded from rat muscle-nerve preparations in vitro after eccentric contraction. J Neurophysiol 94, 2822-2831.
48. Tidball JG & Villalta SA (2010). Regulatory interactions between muscle and the immune system during muscle regeneration. Am J Physiol Regul Integr Comp Physiol 298, R1173-R1187.
49. Üçeyler N, Eberle T, Rolke R, Birklein F & Sommer C (2007). Differential expression patterns of cytokines in complex regional pain syndrome. Pain 132, 195-205.
50. Üçeyler N, Valenza R, Stock M, Schedel R, Sprotte G & Sommer C (2006). Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum 54, 2656-2664.
51. Vale ML, Marques JB, Moreira CA, Rocha FA, Ferreira SH, Poole S, Cunha FQ & Ribeiro RA (2003). Antinociceptive effects of interleukin-4, -10, and -13 on the writhing response in mice and zymosan-induced knee joint incapacitation in rats. J Pharmacol Exp Ther 304, 102-108.
52. vande Vyver M & Myburgh KH (2012). Cytokine and satellite cell responses to muscle damage: interpretation and possible confounding factors in human studies. Muscle Res Cell Motil 33, 177-185.
53. Verri WA Jr, Cunha TM, Parada CA, Poole S, Cunha FQ & Ferreira SH (2006). Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? Pharmacol Ther 112, 116-138.
54. Verri WA Jr, Souto FO, Vieira SM, Almeida SC, Fukada SY, Xu D, Alves-Filho JC, Cunha TM, Guerrero AT, Mattos-Guimaraes RB, Oliveira FR, Teixeira MM, Silva JS, McInnes IB, Ferreira SH, Louzada-Junior P, Liew FY & Cunha FQ (2010). IL-33 induces neutrophil migration in rheumatoid arthritis and is a target of anti-TNF therapy. Ann Rheum Dis 69, 1697-1703.
55. Wang ZH, Zeng XY, Han SP, Fan GX & Wang JY (2012). Interleukin-10 of red nucleus plays anti-allodynia effect in neuropathic pain rats with spared nerve injury. Neurochem Res 37, 1811-1819.
56. Yin Y, Liu W, Ji G & Dai Y (2013). The essential role of p38 MAPK in mediating the interplay of oxLDL and IL-10 in regulating endothelial cell apoptosis. Eur J Cell Biol 92, 150-159.